An observational study in Basal Cell Carcinoma, Lentigo Maligna and Melanoma, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Completed at 1 site in France. Per ClinicalTrials.gov, last updated 2024-06-24.
Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Observational
Reflectance confocal microscopy (RCM) is the reference in vivo imaging technique for identifying malignant melanocytic tumors prior to surgical excision. However, it is not widely used due to its high cost and highly technical and time-consuming nature.
In addition to Reflectance confocal microscopy (RCM), it currently use 2 less expensive dermatoscopes that also allow in vivo diagnosis: super-high magnification dermoscopy (D400) and Fluorescence-Advanced videodermatoscopy (FAV).
Several studies have demonstrated their interest in the in vivo diagnosis of melanocytic tumors, but without any comparison between these methods.
In our current practice, many patients have benefited from these 3 imaging modalities for benign and malignant lesions.
Therefore, our aim is to analyze these images and compare their performance in the diagnosis of benign and malignant pigmented lesions.
389 studies on the registry are indexed under Carcinoma, Basal Cell; 69 are open to participants now.
This study's enrollment of 161 is above the median of 142 across 95 observational studies indexed under Carcinoma, Basal Cell.
Browse Carcinoma, Basal Cell studies →Centre Hospitalier Universitaire de Saint Etienne is the lead sponsor of 597 studies on the registry; 127 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with a pigmented skin lesion of more than 3mm diameter which have benefited systematically of all 3 imaging techniques at the same time, followed by either a surgical excision or annual imaging monitoring.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with a pigmented skin lesion of more than 3mm diameter which have benefited systematically of all 3 imaging techniques at the same time, followed by either a surgical excision or annual imaging monitoring.
Diagnostic Test: Fluorescence-Advanced videodermatoscopy · Diagnostic Test: Reflectance confocal microscopy · Diagnostic Test: Super-high magnification dermoscopy
Datas collected : Presence or absence of atypical roundish cell, dendritic cell, atypical nests, points, folliculotropism, blue homogenous zone, regular honeycomb pattern. Between 10 and 60 images taken by a hand-held camera set directly on the skin lesion, with an oily interface.
Datas collected : Presence or absence of atypical roundish cell, dendritic cell, atypical nests, points, folliculotropism, blue homogenous zone, regular honeycomb pattern. Between 10 and 60 images taken by a hand-held camera set directly on the skin lesion, with an oily interface.
Datas collected : Presence or absence of atypical roundish cell, dendritic cell, atypical nests, points, folliculotropism, blue homogenous zone, regular honeycomb pattern. Between 10 and 60 images taken by a hand-held camera set directly on the skin lesion, with an oily interface.
To compare the the relevance of each technique for the diagnostic of pigmented lesions.
The nature of the tumor is diagnosed by the imaging technique.
Time frame: Day 1
Comparison of performance of imaging techniques
Analyze the results of imaging of each technique.
Time frame: Day 1
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire de Saint Etienne →